Cancer Treatment Centers Of America Launches Innovative Partnership

Cancer Treatment Centers of America (CTCA) is a network of five hospitals that provides cancer treatment across the nation. The organization recently announced a partnership with Allscripts and NantHealth will result in a solution that will streamline the treatment of cancer while not inhibiting the doctor’s clinical workflow. The products and services that will be involved in NantHealth’s eviti which is a clinical decision support platform and Sunrise Electronic Health Record which is supplied by Allscripts.
The Chief Medical Officer of CTCA is Dr. George Daneker, Jr. who works at the Southeastern Regional Medical Center. Dr. Daneker said that this partnership, called Clinical Pathways, will present physicians with all of the cancer treatment options that are appropriate for a particular patient. He also said that this will result in less educated guesswork and help them provide therapies and drugs that are safe and efficient.
According to Wikipedia, CTCA is based in Boca Raton, Florida. It has five hospitals that are strategically located across the continental United States in every region. The organization uses conventional approaches to cancer treatment such as chemotherapy, surgery, immunotherapy, and radiation. Additionally, the doctors at CTCA use therapies to treat the side effects of cancer treatment such as nausea, fatigue, depression, and pain.
Cancer Treatment Centers of America blogĀ https://www.myctca.com/ was founded in 1988 in order to provide a patient-focused approach to cancer treatment that could be modified to fit the individualized needs of each patient. All of the Oncologists at CTCA are board-certified and have specialists in every type of cancer including breast, prostate, cervical, lung, and all of forms of cancer. The founder of the organization was Richard J. Stephenson who had lost his mother to cancer. He discovered during her therapy that there weren’t very good treatment options available and so founded his company in order to offer other patients better rates of survivability.

For further information on CTCA follow them on Facebook and Twitter.

The entrepreneur – Eric Lefkofsky

Eric P. Lefkofsky is an American entrepreneur, born in Detroit, Michigan, in September 1969. Among other things, he is co-founder and Chief Executive Officer of Tempus. He is Jewish and grew up in Southfield, Michigan. Eric Lefkofsky attended the University Of Michigan and graduated in 1991. He proceeded on at University Of Michigan Law School to receive his JD in 1993. Eric Lefkofsky is now a Trustee at Lurie Children’s Hospital of Chicago, and he is a member of The Giving Pledge and committed to donate half of his wealth over his lifetime to philanthropy.

 

Eric Lefkofsky motivation for starting Tempus was personal. He watch a family member actually being treated inside a clinical setting. And he realized how critical it was to bring technology to the very physicians that were seeing patients everyday. Tempus is a health-tech company that facilitate physician to deliver individualize treatment care. Their goal is to live in a world where each patient benefits from the treatment based on the data and knowledge aggregate of all the other patients who have come before him or her. That is what Tempus is delivering, as they can now gather genomic data, allowing physician to make decision while treating patients that could improve patient outcomes. In other words, Tempus.com is a platform or operating system to help physicians in clinic, while treating patients, analyze incredible amounts of data that is specific to a patient and make real-time decisions. This allow Tempus to now have the ability, in a personalize manner, to provide real hope.

 

What makes Tempus’ approach so uniquely innovative is their software platform. The challenges of trying to cut through all kinds of information is miniaturized. To bring genomic data into clinical care, Tempus combined the molecular data with the phenotypic data, and that combination of data will allow for powerful decisions.

 

This is a new and exciting era in modern medicine with Tempus.

 

Find out more here on https://www.facebook.com/eplefkofsky/.